Global Ceftriaxone Market Growth 2022-2028
The global market for Ceftriaxone is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Ceftriaxone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Ceftriaxone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Ceftriaxone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Ceftriaxone market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Ceftriaxone players cover Hikma Pharmaceuticals, Qilu Pharmaceutical, Novartis, Baxter International and Aurobindo Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Ceftriaxone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Ceftriaxone market, with both quantitative and qualitative data, to help readers understand how the Ceftriaxone market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Ceftriaxone market and forecasts the market size by Type (Intravenous Injection and Intramuscular Injection,), by Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Intravenous Injection
Intramuscular Injection
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hikma Pharmaceuticals
Qilu Pharmaceutical
Novartis
Baxter International
Aurobindo Pharma
ACS DOBFAR
Orchid Pharma
Nectar Lifesciences
Lupin Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Ceftriaxone, Research Methodology, etc.
Chapter 2: Executive Summary, global Ceftriaxone market size (sales and revenue) and CAGR, Ceftriaxone market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Ceftriaxone sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Ceftriaxone sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Ceftriaxone market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hikma Pharmaceuticals, Qilu Pharmaceutical, Novartis, Baxter International, Aurobindo Pharma, ACS DOBFAR, Orchid Pharma, Nectar Lifesciences and Lupin Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ceftriaxone Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ceftriaxone by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ceftriaxone by Country/Region, 2017, 2022 & 2028
2.2 Ceftriaxone Segment by Type
2.2.1 Intravenous Injection
2.2.2 Intramuscular Injection
2.3 Ceftriaxone Sales by Type
2.3.1 Global Ceftriaxone Sales Market Share by Type (2017-2022)
2.3.2 Global Ceftriaxone Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ceftriaxone Sale Price by Type (2017-2022)
2.4 Ceftriaxone Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Ceftriaxone Sales by Application
2.5.1 Global Ceftriaxone Sale Market Share by Application (2017-2022)
2.5.2 Global Ceftriaxone Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ceftriaxone Sale Price by Application (2017-2022)
3 Global Ceftriaxone by Company
3.1 Global Ceftriaxone Breakdown Data by Company
3.1.1 Global Ceftriaxone Annual Sales by Company (2020-2022)
3.1.2 Global Ceftriaxone Sales Market Share by Company (2020-2022)
3.2 Global Ceftriaxone Annual Revenue by Company (2020-2022)
3.2.1 Global Ceftriaxone Revenue by Company (2020-2022)
3.2.2 Global Ceftriaxone Revenue Market Share by Company (2020-2022)
3.3 Global Ceftriaxone Sale Price by Company
3.4 Key Manufacturers Ceftriaxone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ceftriaxone Product Location Distribution
3.4.2 Players Ceftriaxone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ceftriaxone by Geographic Region
4.1 World Historic Ceftriaxone Market Size by Geographic Region (2017-2022)
4.1.1 Global Ceftriaxone Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ceftriaxone Annual Revenue by Geographic Region
4.2 World Historic Ceftriaxone Market Size by Country/Region (2017-2022)
4.2.1 Global Ceftriaxone Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ceftriaxone Annual Revenue by Country/Region
4.3 Americas Ceftriaxone Sales Growth
4.4 APAC Ceftriaxone Sales Growth
4.5 Europe Ceftriaxone Sales Growth
4.6 Middle East & Africa Ceftriaxone Sales Growth
5 Americas
5.1 Americas Ceftriaxone Sales by Country
5.1.1 Americas Ceftriaxone Sales by Country (2017-2022)
5.1.2 Americas Ceftriaxone Revenue by Country (2017-2022)
5.2 Americas Ceftriaxone Sales by Type
5.3 Americas Ceftriaxone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ceftriaxone Sales by Region
6.1.1 APAC Ceftriaxone Sales by Region (2017-2022)
6.1.2 APAC Ceftriaxone Revenue by Region (2017-2022)
6.2 APAC Ceftriaxone Sales by Type
6.3 APAC Ceftriaxone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ceftriaxone by Country
7.1.1 Europe Ceftriaxone Sales by Country (2017-2022)
7.1.2 Europe Ceftriaxone Revenue by Country (2017-2022)
7.2 Europe Ceftriaxone Sales by Type
7.3 Europe Ceftriaxone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ceftriaxone by Country
8.1.1 Middle East & Africa Ceftriaxone Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ceftriaxone Revenue by Country (2017-2022)
8.2 Middle East & Africa Ceftriaxone Sales by Type
8.3 Middle East & Africa Ceftriaxone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ceftriaxone
10.3 Manufacturing Process Analysis of Ceftriaxone
10.4 Industry Chain Structure of Ceftriaxone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ceftriaxone Distributors
11.3 Ceftriaxone Customer
12 World Forecast Review for Ceftriaxone by Geographic Region
12.1 Global Ceftriaxone Market Size Forecast by Region
12.1.1 Global Ceftriaxone Forecast by Region (2023-2028)
12.1.2 Global Ceftriaxone Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ceftriaxone Forecast by Type
12.7 Global Ceftriaxone Forecast by Application
13 Key Players Analysis
13.1 Hikma Pharmaceuticals
13.1.1 Hikma Pharmaceuticals Company Information
13.1.2 Hikma Pharmaceuticals Ceftriaxone Product Offered
13.1.3 Hikma Pharmaceuticals Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hikma Pharmaceuticals Main Business Overview
13.1.5 Hikma Pharmaceuticals Latest Developments
13.2 Qilu Pharmaceutical
13.2.1 Qilu Pharmaceutical Company Information
13.2.2 Qilu Pharmaceutical Ceftriaxone Product Offered
13.2.3 Qilu Pharmaceutical Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Qilu Pharmaceutical Main Business Overview
13.2.5 Qilu Pharmaceutical Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Ceftriaxone Product Offered
13.3.3 Novartis Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Baxter International
13.4.1 Baxter International Company Information
13.4.2 Baxter International Ceftriaxone Product Offered
13.4.3 Baxter International Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Baxter International Main Business Overview
13.4.5 Baxter International Latest Developments
13.5 Aurobindo Pharma
13.5.1 Aurobindo Pharma Company Information
13.5.2 Aurobindo Pharma Ceftriaxone Product Offered
13.5.3 Aurobindo Pharma Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aurobindo Pharma Main Business Overview
13.5.5 Aurobindo Pharma Latest Developments
13.6 ACS DOBFAR
13.6.1 ACS DOBFAR Company Information
13.6.2 ACS DOBFAR Ceftriaxone Product Offered
13.6.3 ACS DOBFAR Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 ACS DOBFAR Main Business Overview
13.6.5 ACS DOBFAR Latest Developments
13.7 Orchid Pharma
13.7.1 Orchid Pharma Company Information
13.7.2 Orchid Pharma Ceftriaxone Product Offered
13.7.3 Orchid Pharma Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Orchid Pharma Main Business Overview
13.7.5 Orchid Pharma Latest Developments
13.8 Nectar Lifesciences
13.8.1 Nectar Lifesciences Company Information
13.8.2 Nectar Lifesciences Ceftriaxone Product Offered
13.8.3 Nectar Lifesciences Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Nectar Lifesciences Main Business Overview
13.8.5 Nectar Lifesciences Latest Developments
13.9 Lupin Pharmaceuticals
13.9.1 Lupin Pharmaceuticals Company Information
13.9.2 Lupin Pharmaceuticals Ceftriaxone Product Offered
13.9.3 Lupin Pharmaceuticals Ceftriaxone Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Lupin Pharmaceuticals Main Business Overview
13.9.5 Lupin Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Ceftriaxone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ceftriaxone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intravenous Injection
Table 4. Major Players of Intramuscular Injection
Table 5. Global Ceftriaxone Sales by Type (2017-2022) & (K Units)
Table 6. Global Ceftriaxone Sales Market Share by Type (2017-2022)
Table 7. Global Ceftriaxone Revenue by Type (2017-2022) & ($ million)
Table 8. Global Ceftriaxone Revenue Market Share by Type (2017-2022)
Table 9. Global Ceftriaxone Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Ceftriaxone Sales by Application (2017-2022) & (K Units)
Table 11. Global Ceftriaxone Sales Market Share by Application (2017-2022)
Table 12. Global Ceftriaxone Revenue by Application (2017-2022)
Table 13. Global Ceftriaxone Revenue Market Share by Application (2017-2022)
Table 14. Global Ceftriaxone Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Ceftriaxone Sales by Company (2020-2022) & (K Units)
Table 16. Global Ceftriaxone Sales Market Share by Company (2020-2022)
Table 17. Global Ceftriaxone Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Ceftriaxone Revenue Market Share by Company (2020-2022)
Table 19. Global Ceftriaxone Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Ceftriaxone Producing Area Distribution and Sales Area
Table 21. Players Ceftriaxone Products Offered
Table 22. Ceftriaxone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ceftriaxone Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Ceftriaxone Sales Market Share Geographic Region (2017-2022)
Table 27. Global Ceftriaxone Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Ceftriaxone Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Ceftriaxone Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Ceftriaxone Sales Market Share by Country/Region (2017-2022)
Table 31. Global Ceftriaxone Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Ceftriaxone Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Ceftriaxone Sales by Country (2017-2022) & (K Units)
Table 34. Americas Ceftriaxone Sales Market Share by Country (2017-2022)
Table 35. Americas Ceftriaxone Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Ceftriaxone Revenue Market Share by Country (2017-2022)
Table 37. Americas Ceftriaxone Sales by Type (2017-2022) & (K Units)
Table 38. Americas Ceftriaxone Sales Market Share by Type (2017-2022)
Table 39. Americas Ceftriaxone Sales by Application (2017-2022) & (K Units)
Table 40. Americas Ceftriaxone Sales Market Share by Application (2017-2022)
Table 41. APAC Ceftriaxone Sales by Region (2017-2022) & (K Units)
Table 42. APAC Ceftriaxone Sales Market Share by Region (2017-2022)
Table 43. APAC Ceftriaxone Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Ceftriaxone Revenue Market Share by Region (2017-2022)
Table 45. APAC Ceftriaxone Sales by Type (2017-2022) & (K Units)
Table 46. APAC Ceftriaxone Sales Market Share by Type (2017-2022)
Table 47. APAC Ceftriaxone Sales by Application (2017-2022) & (K Units)
Table 48. APAC Ceftriaxone Sales Market Share by Application (2017-2022)
Table 49. Europe Ceftriaxone Sales by Country (2017-2022) & (K Units)
Table 50. Europe Ceftriaxone Sales Market Share by Country (2017-2022)
Table 51. Europe Ceftriaxone Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Ceftriaxone Revenue Market Share by Country (2017-2022)
Table 53. Europe Ceftriaxone Sales by Type (2017-2022) & (K Units)
Table 54. Europe Ceftriaxone Sales Market Share by Type (2017-2022)
Table 55. Europe Ceftriaxone Sales by Application (2017-2022) & (K Units)
Table 56. Europe Ceftriaxone Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Ceftriaxone Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Ceftriaxone Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Ceftriaxone Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Ceftriaxone Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ceftriaxone Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Ceftriaxone Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Ceftriaxone Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Ceftriaxone Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Ceftriaxone
Table 66. Key Market Challenges & Risks of Ceftriaxone
Table 67. Key Industry Trends of Ceftriaxone
Table 68. Ceftriaxone Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Ceftriaxone Distributors List
Table 71. Ceftriaxone Customer List
Table 72. Global Ceftriaxone Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Ceftriaxone Sales Market Forecast by Region
Table 74. Global Ceftriaxone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Ceftriaxone Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Ceftriaxone Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Ceftriaxone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Ceftriaxone Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Ceftriaxone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Ceftriaxone Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Ceftriaxone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Ceftriaxone Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Ceftriaxone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Ceftriaxone Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Ceftriaxone Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Ceftriaxone Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Ceftriaxone Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Ceftriaxone Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Ceftriaxone Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Ceftriaxone Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Ceftriaxone Revenue Market Share Forecast by Application (2023-2028)
Table 92. Hikma Pharmaceuticals Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 93. Hikma Pharmaceuticals Ceftriaxone Product Offered
Table 94. Hikma Pharmaceuticals Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Hikma Pharmaceuticals Main Business
Table 96. Hikma Pharmaceuticals Latest Developments
Table 97. Qilu Pharmaceutical Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 98. Qilu Pharmaceutical Ceftriaxone Product Offered
Table 99. Qilu Pharmaceutical Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Qilu Pharmaceutical Main Business
Table 101. Qilu Pharmaceutical Latest Developments
Table 102. Novartis Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis Ceftriaxone Product Offered
Table 104. Novartis Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Baxter International Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 108. Baxter International Ceftriaxone Product Offered
Table 109. Baxter International Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Baxter International Main Business
Table 111. Baxter International Latest Developments
Table 112. Aurobindo Pharma Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 113. Aurobindo Pharma Ceftriaxone Product Offered
Table 114. Aurobindo Pharma Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Aurobindo Pharma Main Business
Table 116. Aurobindo Pharma Latest Developments
Table 117. ACS DOBFAR Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 118. ACS DOBFAR Ceftriaxone Product Offered
Table 119. ACS DOBFAR Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. ACS DOBFAR Main Business
Table 121. ACS DOBFAR Latest Developments
Table 122. Orchid Pharma Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 123. Orchid Pharma Ceftriaxone Product Offered
Table 124. Orchid Pharma Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Orchid Pharma Main Business
Table 126. Orchid Pharma Latest Developments
Table 127. Nectar Lifesciences Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 128. Nectar Lifesciences Ceftriaxone Product Offered
Table 129. Nectar Lifesciences Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Nectar Lifesciences Main Business
Table 131. Nectar Lifesciences Latest Developments
Table 132. Lupin Pharmaceuticals Basic Information, Ceftriaxone Manufacturing Base, Sales Area and Its Competitors
Table 133. Lupin Pharmaceuticals Ceftriaxone Product Offered
Table 134. Lupin Pharmaceuticals Ceftriaxone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Lupin Pharmaceuticals Main Business
Table 136. Lupin Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Ceftriaxone
Figure 2. Ceftriaxone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ceftriaxone Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ceftriaxone Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ceftriaxone Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intravenous Injection
Figure 10. Product Picture of Intramuscular Injection
Figure 11. Global Ceftriaxone Sales Market Share by Type in 2021
Figure 12. Global Ceftriaxone Revenue Market Share by Type (2017-2022)
Figure 13. Ceftriaxone Consumed in Hospital Pharmacies
Figure 14. Global Ceftriaxone Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 15. Ceftriaxone Consumed in Retail Pharmacies
Figure 16. Global Ceftriaxone Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 17. Ceftriaxone Consumed in Online Pharmacies
Figure 18. Global Ceftriaxone Market: Online Pharmacies (2017-2022) & (K Units)
Figure 19. Global Ceftriaxone Sales Market Share by Application (2017-2022)
Figure 20. Global Ceftriaxone Revenue Market Share by Application in 2021
Figure 21. Ceftriaxone Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Ceftriaxone Revenue Market Share by Company in 2021
Figure 23. Global Ceftriaxone Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Ceftriaxone Revenue Market Share by Geographic Region in 2021
Figure 25. Global Ceftriaxone Sales Market Share by Region (2017-2022)
Figure 26. Global Ceftriaxone Revenue Market Share by Country/Region in 2021
Figure 27. Americas Ceftriaxone Sales 2017-2022 (K Units)
Figure 28. Americas Ceftriaxone Revenue 2017-2022 ($ Millions)
Figure 29. APAC Ceftriaxone Sales 2017-2022 (K Units)
Figure 30. APAC Ceftriaxone Revenue 2017-2022 ($ Millions)
Figure 31. Europe Ceftriaxone Sales 2017-2022 (K Units)
Figure 32. Europe Ceftriaxone Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Ceftriaxone Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Ceftriaxone Revenue 2017-2022 ($ Millions)
Figure 35. Americas Ceftriaxone Sales Market Share by Country in 2021
Figure 36. Americas Ceftriaxone Revenue Market Share by Country in 2021
Figure 37. United States Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Ceftriaxone Sales Market Share by Region in 2021
Figure 42. APAC Ceftriaxone Revenue Market Share by Regions in 2021
Figure 43. China Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Ceftriaxone Sales Market Share by Country in 2021
Figure 50. Europe Ceftriaxone Revenue Market Share by Country in 2021
Figure 51. Germany Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Ceftriaxone Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Ceftriaxone Revenue Market Share by Country in 2021
Figure 58. Egypt Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Ceftriaxone Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Ceftriaxone in 2021
Figure 64. Manufacturing Process Analysis of Ceftriaxone
Figure 65. Industry Chain Structure of Ceftriaxone
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets